Pharma Journalist 9038 posts 0 comments

Passage Bio, Inc. a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system (CNS) disorders, and Catalent, the leading global…
Read More...

PostEra, a biotechnology company specializing in machine learning solutions for preclinical drug discovery,  announced a strategic partnership with Pfizer Inc. with the goal of…
Read More...

Cybin Inc. announced the signing of a definitive agreement to acquire 100% of the shares in Adelia Therapeutics Inc. for up to CDN$20,161,575 (approximately USD$15.75 million) in an…
Read More...

Aligos Therapeutics, Inc. announced that it has entered into an Exclusive License and Research Collaboration Agreement with Merck, known as MSD outside the United States and Canada,…
Read More...

Syros Pharmaceuticals, a leader in the development of medicines that control the expression of genes, announced that it has acquired from Orsenix, LLC (Orsenix) all of its assets…
Read More...

SMi Reports: SMi Group are delighted to announce that Séverine Duband, Global Category Manager, Nemera will be a speaker at the Pre-filled Syringes Europe Conference SMi Group is…
Read More...

Bayer and Atara Biotherapeutics, Inc. announced an exclusive worldwide license agreement and research, development and manufacturing collaboration for mesothelin-directed CAR T-cell…
Read More...

Eli Lilly and Company and UnitedHealth Group announced a partnership to conduct a pragmatic study of bamlanivimab (LY-CoV555) in high-risk, COVID-19 infected individuals.…
Read More...

Y-mAbs Therapeutics, Inc. a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment…
Read More...

Tevard Biosciences, a privately-held biotechnology company pioneering tRNA-based gene therapies, and Zogenix, a global biopharmaceutical company developing and commercializing rare…
Read More...